pricing and reimbursement
Portuguese Hospitals Block Access to New Medicines as Retail Drug Sector Expected to Meet Savings Goal
September 29 by Tania Rodrigues, an analyst at IHS Global InsightAccess to expensive medicines is becoming increasingly difficult in Portuguese public hospitals, while savings with retail pharmacy expenditure are expected to be better than projections in the Memora...
Are Orphan Drugs Still a Licence to Print Money?
July 20 by Andrea CharlesIn this podcast Donald Macarthur, global pharmaceutical business analyst, speaks to Andrea Charles from Pharma IQ, about Pharma's steps into the orphan drug market and whether payers can afford to fun...
